March 27, 2024Open Access

Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Tumor microenvironment (TME) heterogeneity leads to a discrepancy in survival prognosis and clinical treatment response for patients with HCC. The clinical applications of documented molecular subtypes are constrained by several issues.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Chen et al. (Wed,) studied this question.

synapsesocial.com/papers/68e720ddb6db64358769af6a https://doi.org/https://doi.org/10.1097/hep.0000000000000869

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations2022 · 759 citations
2A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers2012 · 89 citations
3Oncology Meets Immunology: The Cancer-Immunity Cycle2013 · 6,910 citations
4Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade2017 · 5,349 citations
5Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma2016 · 3,157 citations

Me gusta

Guardar

Ver artículo completo